Global Genetically Modified Drug Market Growth 2026-2032
The global Genetically Modified Drug market size is predicted to grow from US$ 2667 million in 2025 to US$ 4038 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032.
Drugs made by genetically modified means are also called 'biological drugs'
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LP Information, Inc. (LPI) ' newest research report, the ?Genetically Modified Drug Industry Forecast? looks at past sales and reviews total world Genetically Modified Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Genetically Modified Drug sales for 2026 through 2032. With Genetically Modified Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genetically Modified Drug industry.
This Insight Report provides a comprehensive analysis of the global Genetically Modified Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genetically Modified Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Genetically Modified Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genetically Modified Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genetically Modified Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Genetically Modified Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Drugs made by genetically modified means are also called 'biological drugs'
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LP Information, Inc. (LPI) ' newest research report, the ?Genetically Modified Drug Industry Forecast? looks at past sales and reviews total world Genetically Modified Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Genetically Modified Drug sales for 2026 through 2032. With Genetically Modified Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genetically Modified Drug industry.
This Insight Report provides a comprehensive analysis of the global Genetically Modified Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genetically Modified Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Genetically Modified Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genetically Modified Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genetically Modified Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Genetically Modified Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Transgenic Animal
- Transgenic Plant
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- LFB Biotechnologies SA
- Pharming Group NV
- Pfizer
- Roche
- Abbott Laboratories
- Johnson & Johnson
- Merck & Co.
- Amgen
- F. Hoffmann-La Roche
- Sanofi
- Novartis
- Eli Lilly
- Takeda
- Baxter
- GlaxoSmithKline
- What is the 10-year outlook for the global Genetically Modified Drug market?
- What factors are driving Genetically Modified Drug market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Genetically Modified Drug market opportunities vary by end market size?
- How does Genetically Modified Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Genetically Modified Drug Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Genetically Modified Drug by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Genetically Modified Drug by Country/Region, 2021, 2025 & 2032
2.2 Genetically Modified Drug Segment by Type
2.2.1 Transgenic Animal
2.2.2 Transgenic Plant
2.2.3 Genetically Modified Drug Sales by Type
2.2.3.1 Global Genetically Modified Drug Sales Market Share by Type (2021-2026)
2.2.3.2 Global Genetically Modified Drug Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Genetically Modified Drug Sale Price by Type (2021-2026)
2.3 Genetically Modified Drug Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Genetically Modified Drug Sales by Application
2.3.3.1 Global Genetically Modified Drug Sale Market Share by Application (2021-2026)
2.3.3.2 Global Genetically Modified Drug Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Genetically Modified Drug Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Genetically Modified Drug Breakdown Data by Company
3.1.1 Global Genetically Modified Drug Annual Sales by Company (2021-2026)
3.1.2 Global Genetically Modified Drug Sales Market Share by Company (2021-2026)
3.2 Global Genetically Modified Drug Annual Revenue by Company (2021-2026)
3.2.1 Global Genetically Modified Drug Revenue by Company (2021-2026)
3.2.2 Global Genetically Modified Drug Revenue Market Share by Company (2021-2026)
3.3 Global Genetically Modified Drug Sale Price by Company
3.4 Key Manufacturers Genetically Modified Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Genetically Modified Drug Product Location Distribution
3.4.2 Players Genetically Modified Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GENETICALLY MODIFIED DRUG BY GEOGRAPHIC REGION
4.1 World Historic Genetically Modified Drug Market Size by Geographic Region (2021-2026)
4.1.1 Global Genetically Modified Drug Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Genetically Modified Drug Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Genetically Modified Drug Market Size by Country/Region (2021-2026)
4.2.1 Global Genetically Modified Drug Annual Sales by Country/Region (2021-2026)
4.2.2 Global Genetically Modified Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Genetically Modified Drug Sales Growth
4.4 APAC Genetically Modified Drug Sales Growth
4.5 Europe Genetically Modified Drug Sales Growth
4.6 Middle East & Africa Genetically Modified Drug Sales Growth
5 AMERICAS
5.1 Americas Genetically Modified Drug Sales by Country
5.1.1 Americas Genetically Modified Drug Sales by Country (2021-2026)
5.1.2 Americas Genetically Modified Drug Revenue by Country (2021-2026)
5.2 Americas Genetically Modified Drug Sales by Type (2021-2026)
5.3 Americas Genetically Modified Drug Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genetically Modified Drug Sales by Region
6.1.1 APAC Genetically Modified Drug Sales by Region (2021-2026)
6.1.2 APAC Genetically Modified Drug Revenue by Region (2021-2026)
6.2 APAC Genetically Modified Drug Sales by Type (2021-2026)
6.3 APAC Genetically Modified Drug Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Genetically Modified Drug by Country
7.1.1 Europe Genetically Modified Drug Sales by Country (2021-2026)
7.1.2 Europe Genetically Modified Drug Revenue by Country (2021-2026)
7.2 Europe Genetically Modified Drug Sales by Type (2021-2026)
7.3 Europe Genetically Modified Drug Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Genetically Modified Drug by Country
8.1.1 Middle East & Africa Genetically Modified Drug Sales by Country (2021-2026)
8.1.2 Middle East & Africa Genetically Modified Drug Revenue by Country (2021-2026)
8.2 Middle East & Africa Genetically Modified Drug Sales by Type (2021-2026)
8.3 Middle East & Africa Genetically Modified Drug Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Genetically Modified Drug
10.3 Manufacturing Process Analysis of Genetically Modified Drug
10.4 Industry Chain Structure of Genetically Modified Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Genetically Modified Drug Distributors
11.3 Genetically Modified Drug Customer
12 WORLD FORECAST REVIEW FOR GENETICALLY MODIFIED DRUG BY GEOGRAPHIC REGION
12.1 Global Genetically Modified Drug Market Size Forecast by Region
12.1.1 Global Genetically Modified Drug Forecast by Region (2027-2032)
12.1.2 Global Genetically Modified Drug Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Genetically Modified Drug Forecast by Type (2027-2032)
12.7 Global Genetically Modified Drug Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 LFB Biotechnologies SA
13.1.1 LFB Biotechnologies SA Company Information
13.1.2 LFB Biotechnologies SA Genetically Modified Drug Product Portfolios and Specifications
13.1.3 LFB Biotechnologies SA Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 LFB Biotechnologies SA Main Business Overview
13.1.5 LFB Biotechnologies SA Latest Developments
13.2 Pharming Group NV
13.2.1 Pharming Group NV Company Information
13.2.2 Pharming Group NV Genetically Modified Drug Product Portfolios and Specifications
13.2.3 Pharming Group NV Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pharming Group NV Main Business Overview
13.2.5 Pharming Group NV Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Genetically Modified Drug Product Portfolios and Specifications
13.3.3 Pfizer Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Roche
13.4.1 Roche Company Information
13.4.2 Roche Genetically Modified Drug Product Portfolios and Specifications
13.4.3 Roche Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Roche Main Business Overview
13.4.5 Roche Latest Developments
13.5 Abbott Laboratories
13.5.1 Abbott Laboratories Company Information
13.5.2 Abbott Laboratories Genetically Modified Drug Product Portfolios and Specifications
13.5.3 Abbott Laboratories Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Abbott Laboratories Main Business Overview
13.5.5 Abbott Laboratories Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Genetically Modified Drug Product Portfolios and Specifications
13.6.3 Johnson & Johnson Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 Merck & Co.
13.7.1 Merck & Co. Company Information
13.7.2 Merck & Co. Genetically Modified Drug Product Portfolios and Specifications
13.7.3 Merck & Co. Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Merck & Co. Main Business Overview
13.7.5 Merck & Co. Latest Developments
13.8 Amgen
13.8.1 Amgen Company Information
13.8.2 Amgen Genetically Modified Drug Product Portfolios and Specifications
13.8.3 Amgen Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Amgen Main Business Overview
13.8.5 Amgen Latest Developments
13.9 F. Hoffmann-La Roche
13.9.1 F. Hoffmann-La Roche Company Information
13.9.2 F. Hoffmann-La Roche Genetically Modified Drug Product Portfolios and Specifications
13.9.3 F. Hoffmann-La Roche Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 F. Hoffmann-La Roche Main Business Overview
13.9.5 F. Hoffmann-La Roche Latest Developments
13.10 Sanofi
13.10.1 Sanofi Company Information
13.10.2 Sanofi Genetically Modified Drug Product Portfolios and Specifications
13.10.3 Sanofi Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Sanofi Main Business Overview
13.10.5 Sanofi Latest Developments
13.11 Novartis
13.11.1 Novartis Company Information
13.11.2 Novartis Genetically Modified Drug Product Portfolios and Specifications
13.11.3 Novartis Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Novartis Main Business Overview
13.11.5 Novartis Latest Developments
13.12 Eli Lilly
13.12.1 Eli Lilly Company Information
13.12.2 Eli Lilly Genetically Modified Drug Product Portfolios and Specifications
13.12.3 Eli Lilly Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Eli Lilly Main Business Overview
13.12.5 Eli Lilly Latest Developments
13.13 Takeda
13.13.1 Takeda Company Information
13.13.2 Takeda Genetically Modified Drug Product Portfolios and Specifications
13.13.3 Takeda Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Takeda Main Business Overview
13.13.5 Takeda Latest Developments
13.14 Baxter
13.14.1 Baxter Company Information
13.14.2 Baxter Genetically Modified Drug Product Portfolios and Specifications
13.14.3 Baxter Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Baxter Main Business Overview
13.14.5 Baxter Latest Developments
13.15 GlaxoSmithKline
13.15.1 GlaxoSmithKline Company Information
13.15.2 GlaxoSmithKline Genetically Modified Drug Product Portfolios and Specifications
13.15.3 GlaxoSmithKline Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 GlaxoSmithKline Main Business Overview
13.15.5 GlaxoSmithKline Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Genetically Modified Drug Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Genetically Modified Drug by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Genetically Modified Drug by Country/Region, 2021, 2025 & 2032
2.2 Genetically Modified Drug Segment by Type
2.2.1 Transgenic Animal
2.2.2 Transgenic Plant
2.2.3 Genetically Modified Drug Sales by Type
2.2.3.1 Global Genetically Modified Drug Sales Market Share by Type (2021-2026)
2.2.3.2 Global Genetically Modified Drug Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Genetically Modified Drug Sale Price by Type (2021-2026)
2.3 Genetically Modified Drug Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Genetically Modified Drug Sales by Application
2.3.3.1 Global Genetically Modified Drug Sale Market Share by Application (2021-2026)
2.3.3.2 Global Genetically Modified Drug Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Genetically Modified Drug Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Genetically Modified Drug Breakdown Data by Company
3.1.1 Global Genetically Modified Drug Annual Sales by Company (2021-2026)
3.1.2 Global Genetically Modified Drug Sales Market Share by Company (2021-2026)
3.2 Global Genetically Modified Drug Annual Revenue by Company (2021-2026)
3.2.1 Global Genetically Modified Drug Revenue by Company (2021-2026)
3.2.2 Global Genetically Modified Drug Revenue Market Share by Company (2021-2026)
3.3 Global Genetically Modified Drug Sale Price by Company
3.4 Key Manufacturers Genetically Modified Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Genetically Modified Drug Product Location Distribution
3.4.2 Players Genetically Modified Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GENETICALLY MODIFIED DRUG BY GEOGRAPHIC REGION
4.1 World Historic Genetically Modified Drug Market Size by Geographic Region (2021-2026)
4.1.1 Global Genetically Modified Drug Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Genetically Modified Drug Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Genetically Modified Drug Market Size by Country/Region (2021-2026)
4.2.1 Global Genetically Modified Drug Annual Sales by Country/Region (2021-2026)
4.2.2 Global Genetically Modified Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Genetically Modified Drug Sales Growth
4.4 APAC Genetically Modified Drug Sales Growth
4.5 Europe Genetically Modified Drug Sales Growth
4.6 Middle East & Africa Genetically Modified Drug Sales Growth
5 AMERICAS
5.1 Americas Genetically Modified Drug Sales by Country
5.1.1 Americas Genetically Modified Drug Sales by Country (2021-2026)
5.1.2 Americas Genetically Modified Drug Revenue by Country (2021-2026)
5.2 Americas Genetically Modified Drug Sales by Type (2021-2026)
5.3 Americas Genetically Modified Drug Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genetically Modified Drug Sales by Region
6.1.1 APAC Genetically Modified Drug Sales by Region (2021-2026)
6.1.2 APAC Genetically Modified Drug Revenue by Region (2021-2026)
6.2 APAC Genetically Modified Drug Sales by Type (2021-2026)
6.3 APAC Genetically Modified Drug Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Genetically Modified Drug by Country
7.1.1 Europe Genetically Modified Drug Sales by Country (2021-2026)
7.1.2 Europe Genetically Modified Drug Revenue by Country (2021-2026)
7.2 Europe Genetically Modified Drug Sales by Type (2021-2026)
7.3 Europe Genetically Modified Drug Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Genetically Modified Drug by Country
8.1.1 Middle East & Africa Genetically Modified Drug Sales by Country (2021-2026)
8.1.2 Middle East & Africa Genetically Modified Drug Revenue by Country (2021-2026)
8.2 Middle East & Africa Genetically Modified Drug Sales by Type (2021-2026)
8.3 Middle East & Africa Genetically Modified Drug Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Genetically Modified Drug
10.3 Manufacturing Process Analysis of Genetically Modified Drug
10.4 Industry Chain Structure of Genetically Modified Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Genetically Modified Drug Distributors
11.3 Genetically Modified Drug Customer
12 WORLD FORECAST REVIEW FOR GENETICALLY MODIFIED DRUG BY GEOGRAPHIC REGION
12.1 Global Genetically Modified Drug Market Size Forecast by Region
12.1.1 Global Genetically Modified Drug Forecast by Region (2027-2032)
12.1.2 Global Genetically Modified Drug Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Genetically Modified Drug Forecast by Type (2027-2032)
12.7 Global Genetically Modified Drug Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 LFB Biotechnologies SA
13.1.1 LFB Biotechnologies SA Company Information
13.1.2 LFB Biotechnologies SA Genetically Modified Drug Product Portfolios and Specifications
13.1.3 LFB Biotechnologies SA Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 LFB Biotechnologies SA Main Business Overview
13.1.5 LFB Biotechnologies SA Latest Developments
13.2 Pharming Group NV
13.2.1 Pharming Group NV Company Information
13.2.2 Pharming Group NV Genetically Modified Drug Product Portfolios and Specifications
13.2.3 Pharming Group NV Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pharming Group NV Main Business Overview
13.2.5 Pharming Group NV Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Genetically Modified Drug Product Portfolios and Specifications
13.3.3 Pfizer Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Roche
13.4.1 Roche Company Information
13.4.2 Roche Genetically Modified Drug Product Portfolios and Specifications
13.4.3 Roche Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Roche Main Business Overview
13.4.5 Roche Latest Developments
13.5 Abbott Laboratories
13.5.1 Abbott Laboratories Company Information
13.5.2 Abbott Laboratories Genetically Modified Drug Product Portfolios and Specifications
13.5.3 Abbott Laboratories Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Abbott Laboratories Main Business Overview
13.5.5 Abbott Laboratories Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Genetically Modified Drug Product Portfolios and Specifications
13.6.3 Johnson & Johnson Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 Merck & Co.
13.7.1 Merck & Co. Company Information
13.7.2 Merck & Co. Genetically Modified Drug Product Portfolios and Specifications
13.7.3 Merck & Co. Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Merck & Co. Main Business Overview
13.7.5 Merck & Co. Latest Developments
13.8 Amgen
13.8.1 Amgen Company Information
13.8.2 Amgen Genetically Modified Drug Product Portfolios and Specifications
13.8.3 Amgen Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Amgen Main Business Overview
13.8.5 Amgen Latest Developments
13.9 F. Hoffmann-La Roche
13.9.1 F. Hoffmann-La Roche Company Information
13.9.2 F. Hoffmann-La Roche Genetically Modified Drug Product Portfolios and Specifications
13.9.3 F. Hoffmann-La Roche Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 F. Hoffmann-La Roche Main Business Overview
13.9.5 F. Hoffmann-La Roche Latest Developments
13.10 Sanofi
13.10.1 Sanofi Company Information
13.10.2 Sanofi Genetically Modified Drug Product Portfolios and Specifications
13.10.3 Sanofi Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Sanofi Main Business Overview
13.10.5 Sanofi Latest Developments
13.11 Novartis
13.11.1 Novartis Company Information
13.11.2 Novartis Genetically Modified Drug Product Portfolios and Specifications
13.11.3 Novartis Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Novartis Main Business Overview
13.11.5 Novartis Latest Developments
13.12 Eli Lilly
13.12.1 Eli Lilly Company Information
13.12.2 Eli Lilly Genetically Modified Drug Product Portfolios and Specifications
13.12.3 Eli Lilly Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Eli Lilly Main Business Overview
13.12.5 Eli Lilly Latest Developments
13.13 Takeda
13.13.1 Takeda Company Information
13.13.2 Takeda Genetically Modified Drug Product Portfolios and Specifications
13.13.3 Takeda Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Takeda Main Business Overview
13.13.5 Takeda Latest Developments
13.14 Baxter
13.14.1 Baxter Company Information
13.14.2 Baxter Genetically Modified Drug Product Portfolios and Specifications
13.14.3 Baxter Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Baxter Main Business Overview
13.14.5 Baxter Latest Developments
13.15 GlaxoSmithKline
13.15.1 GlaxoSmithKline Company Information
13.15.2 GlaxoSmithKline Genetically Modified Drug Product Portfolios and Specifications
13.15.3 GlaxoSmithKline Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 GlaxoSmithKline Main Business Overview
13.15.5 GlaxoSmithKline Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Genetically Modified Drug Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Genetically Modified Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Transgenic Animal
Table 4. Major Players of Transgenic Plant
Table 5. Global Genetically Modified Drug Sales by Type (2021-2026) & (K Units)
Table 6. Global Genetically Modified Drug Sales Market Share by Type (2021-2026)
Table 7. Global Genetically Modified Drug Revenue by Type (2021-2026) & ($ million)
Table 8. Global Genetically Modified Drug Revenue Market Share by Type (2021-2026)
Table 9. Global Genetically Modified Drug Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Genetically Modified Drug Sale by Application (2021-2026) & (K Units)
Table 11. Global Genetically Modified Drug Sale Market Share by Application (2021-2026)
Table 12. Global Genetically Modified Drug Revenue by Application (2021-2026) & ($ million)
Table 13. Global Genetically Modified Drug Revenue Market Share by Application (2021-2026)
Table 14. Global Genetically Modified Drug Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Genetically Modified Drug Sales by Company (2021-2026) & (K Units)
Table 16. Global Genetically Modified Drug Sales Market Share by Company (2021-2026)
Table 17. Global Genetically Modified Drug Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Genetically Modified Drug Revenue Market Share by Company (2021-2026)
Table 19. Global Genetically Modified Drug Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Genetically Modified Drug Producing Area Distribution and Sales Area
Table 21. Players Genetically Modified Drug Products Offered
Table 22. Genetically Modified Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Genetically Modified Drug Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Genetically Modified Drug Sales Market Share Geographic Region (2021-2026)
Table 27. Global Genetically Modified Drug Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Genetically Modified Drug Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Genetically Modified Drug Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Genetically Modified Drug Sales Market Share by Country/Region (2021-2026)
Table 31. Global Genetically Modified Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Genetically Modified Drug Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Genetically Modified Drug Sales by Country (2021-2026) & (K Units)
Table 34. Americas Genetically Modified Drug Sales Market Share by Country (2021-2026)
Table 35. Americas Genetically Modified Drug Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Genetically Modified Drug Sales by Type (2021-2026) & (K Units)
Table 37. Americas Genetically Modified Drug Sales by Application (2021-2026) & (K Units)
Table 38. APAC Genetically Modified Drug Sales by Region (2021-2026) & (K Units)
Table 39. APAC Genetically Modified Drug Sales Market Share by Region (2021-2026)
Table 40. APAC Genetically Modified Drug Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Genetically Modified Drug Sales by Type (2021-2026) & (K Units)
Table 42. APAC Genetically Modified Drug Sales by Application (2021-2026) & (K Units)
Table 43. Europe Genetically Modified Drug Sales by Country (2021-2026) & (K Units)
Table 44. Europe Genetically Modified Drug Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Genetically Modified Drug Sales by Type (2021-2026) & (K Units)
Table 46. Europe Genetically Modified Drug Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Genetically Modified Drug Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Genetically Modified Drug Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Genetically Modified Drug Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Genetically Modified Drug Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Genetically Modified Drug
Table 52. Key Market Challenges & Risks of Genetically Modified Drug
Table 53. Key Industry Trends of Genetically Modified Drug
Table 54. Genetically Modified Drug Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Genetically Modified Drug Distributors List
Table 57. Genetically Modified Drug Customer List
Table 58. Global Genetically Modified Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Genetically Modified Drug Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Genetically Modified Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Genetically Modified Drug Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Genetically Modified Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Genetically Modified Drug Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Genetically Modified Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Genetically Modified Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Genetically Modified Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Genetically Modified Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Genetically Modified Drug Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Genetically Modified Drug Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Genetically Modified Drug Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Genetically Modified Drug Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. LFB Biotechnologies SA Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 73. LFB Biotechnologies SA Genetically Modified Drug Product Portfolios and Specifications
Table 74. LFB Biotechnologies SA Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. LFB Biotechnologies SA Main Business
Table 76. LFB Biotechnologies SA Latest Developments
Table 77. Pharming Group NV Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 78. Pharming Group NV Genetically Modified Drug Product Portfolios and Specifications
Table 79. Pharming Group NV Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Pharming Group NV Main Business
Table 81. Pharming Group NV Latest Developments
Table 82. Pfizer Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 83. Pfizer Genetically Modified Drug Product Portfolios and Specifications
Table 84. Pfizer Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Pfizer Main Business
Table 86. Pfizer Latest Developments
Table 87. Roche Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 88. Roche Genetically Modified Drug Product Portfolios and Specifications
Table 89. Roche Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Roche Main Business
Table 91. Roche Latest Developments
Table 92. Abbott Laboratories Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. Abbott Laboratories Genetically Modified Drug Product Portfolios and Specifications
Table 94. Abbott Laboratories Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Abbott Laboratories Main Business
Table 96. Abbott Laboratories Latest Developments
Table 97. Johnson & Johnson Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. Johnson & Johnson Genetically Modified Drug Product Portfolios and Specifications
Table 99. Johnson & Johnson Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Johnson & Johnson Main Business
Table 101. Johnson & Johnson Latest Developments
Table 102. Merck & Co. Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. Merck & Co. Genetically Modified Drug Product Portfolios and Specifications
Table 104. Merck & Co. Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Merck & Co. Main Business
Table 106. Merck & Co. Latest Developments
Table 107. Amgen Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Amgen Genetically Modified Drug Product Portfolios and Specifications
Table 109. Amgen Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Amgen Main Business
Table 111. Amgen Latest Developments
Table 112. F. Hoffmann-La Roche Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. F. Hoffmann-La Roche Genetically Modified Drug Product Portfolios and Specifications
Table 114. F. Hoffmann-La Roche Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. F. Hoffmann-La Roche Main Business
Table 116. F. Hoffmann-La Roche Latest Developments
Table 117. Sanofi Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. Sanofi Genetically Modified Drug Product Portfolios and Specifications
Table 119. Sanofi Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Sanofi Main Business
Table 121. Sanofi Latest Developments
Table 122. Novartis Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 123. Novartis Genetically Modified Drug Product Portfolios and Specifications
Table 124. Novartis Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Novartis Main Business
Table 126. Novartis Latest Developments
Table 127. Eli Lilly Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 128. Eli Lilly Genetically Modified Drug Product Portfolios and Specifications
Table 129. Eli Lilly Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Eli Lilly Main Business
Table 131. Eli Lilly Latest Developments
Table 132. Takeda Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 133. Takeda Genetically Modified Drug Product Portfolios and Specifications
Table 134. Takeda Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Takeda Main Business
Table 136. Takeda Latest Developments
Table 137. Baxter Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 138. Baxter Genetically Modified Drug Product Portfolios and Specifications
Table 139. Baxter Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Baxter Main Business
Table 141. Baxter Latest Developments
Table 142. GlaxoSmithKline Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 143. GlaxoSmithKline Genetically Modified Drug Product Portfolios and Specifications
Table 144. GlaxoSmithKline Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. GlaxoSmithKline Main Business
Table 146. GlaxoSmithKline Latest Developments
Table 1. Genetically Modified Drug Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Genetically Modified Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Transgenic Animal
Table 4. Major Players of Transgenic Plant
Table 5. Global Genetically Modified Drug Sales by Type (2021-2026) & (K Units)
Table 6. Global Genetically Modified Drug Sales Market Share by Type (2021-2026)
Table 7. Global Genetically Modified Drug Revenue by Type (2021-2026) & ($ million)
Table 8. Global Genetically Modified Drug Revenue Market Share by Type (2021-2026)
Table 9. Global Genetically Modified Drug Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Genetically Modified Drug Sale by Application (2021-2026) & (K Units)
Table 11. Global Genetically Modified Drug Sale Market Share by Application (2021-2026)
Table 12. Global Genetically Modified Drug Revenue by Application (2021-2026) & ($ million)
Table 13. Global Genetically Modified Drug Revenue Market Share by Application (2021-2026)
Table 14. Global Genetically Modified Drug Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Genetically Modified Drug Sales by Company (2021-2026) & (K Units)
Table 16. Global Genetically Modified Drug Sales Market Share by Company (2021-2026)
Table 17. Global Genetically Modified Drug Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Genetically Modified Drug Revenue Market Share by Company (2021-2026)
Table 19. Global Genetically Modified Drug Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Genetically Modified Drug Producing Area Distribution and Sales Area
Table 21. Players Genetically Modified Drug Products Offered
Table 22. Genetically Modified Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Genetically Modified Drug Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Genetically Modified Drug Sales Market Share Geographic Region (2021-2026)
Table 27. Global Genetically Modified Drug Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Genetically Modified Drug Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Genetically Modified Drug Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Genetically Modified Drug Sales Market Share by Country/Region (2021-2026)
Table 31. Global Genetically Modified Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Genetically Modified Drug Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Genetically Modified Drug Sales by Country (2021-2026) & (K Units)
Table 34. Americas Genetically Modified Drug Sales Market Share by Country (2021-2026)
Table 35. Americas Genetically Modified Drug Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Genetically Modified Drug Sales by Type (2021-2026) & (K Units)
Table 37. Americas Genetically Modified Drug Sales by Application (2021-2026) & (K Units)
Table 38. APAC Genetically Modified Drug Sales by Region (2021-2026) & (K Units)
Table 39. APAC Genetically Modified Drug Sales Market Share by Region (2021-2026)
Table 40. APAC Genetically Modified Drug Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Genetically Modified Drug Sales by Type (2021-2026) & (K Units)
Table 42. APAC Genetically Modified Drug Sales by Application (2021-2026) & (K Units)
Table 43. Europe Genetically Modified Drug Sales by Country (2021-2026) & (K Units)
Table 44. Europe Genetically Modified Drug Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Genetically Modified Drug Sales by Type (2021-2026) & (K Units)
Table 46. Europe Genetically Modified Drug Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Genetically Modified Drug Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Genetically Modified Drug Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Genetically Modified Drug Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Genetically Modified Drug Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Genetically Modified Drug
Table 52. Key Market Challenges & Risks of Genetically Modified Drug
Table 53. Key Industry Trends of Genetically Modified Drug
Table 54. Genetically Modified Drug Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Genetically Modified Drug Distributors List
Table 57. Genetically Modified Drug Customer List
Table 58. Global Genetically Modified Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Genetically Modified Drug Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Genetically Modified Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Genetically Modified Drug Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Genetically Modified Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Genetically Modified Drug Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Genetically Modified Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Genetically Modified Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Genetically Modified Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Genetically Modified Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Genetically Modified Drug Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Genetically Modified Drug Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Genetically Modified Drug Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Genetically Modified Drug Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. LFB Biotechnologies SA Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 73. LFB Biotechnologies SA Genetically Modified Drug Product Portfolios and Specifications
Table 74. LFB Biotechnologies SA Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. LFB Biotechnologies SA Main Business
Table 76. LFB Biotechnologies SA Latest Developments
Table 77. Pharming Group NV Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 78. Pharming Group NV Genetically Modified Drug Product Portfolios and Specifications
Table 79. Pharming Group NV Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Pharming Group NV Main Business
Table 81. Pharming Group NV Latest Developments
Table 82. Pfizer Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 83. Pfizer Genetically Modified Drug Product Portfolios and Specifications
Table 84. Pfizer Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Pfizer Main Business
Table 86. Pfizer Latest Developments
Table 87. Roche Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 88. Roche Genetically Modified Drug Product Portfolios and Specifications
Table 89. Roche Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Roche Main Business
Table 91. Roche Latest Developments
Table 92. Abbott Laboratories Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. Abbott Laboratories Genetically Modified Drug Product Portfolios and Specifications
Table 94. Abbott Laboratories Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Abbott Laboratories Main Business
Table 96. Abbott Laboratories Latest Developments
Table 97. Johnson & Johnson Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. Johnson & Johnson Genetically Modified Drug Product Portfolios and Specifications
Table 99. Johnson & Johnson Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Johnson & Johnson Main Business
Table 101. Johnson & Johnson Latest Developments
Table 102. Merck & Co. Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. Merck & Co. Genetically Modified Drug Product Portfolios and Specifications
Table 104. Merck & Co. Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Merck & Co. Main Business
Table 106. Merck & Co. Latest Developments
Table 107. Amgen Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Amgen Genetically Modified Drug Product Portfolios and Specifications
Table 109. Amgen Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Amgen Main Business
Table 111. Amgen Latest Developments
Table 112. F. Hoffmann-La Roche Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. F. Hoffmann-La Roche Genetically Modified Drug Product Portfolios and Specifications
Table 114. F. Hoffmann-La Roche Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. F. Hoffmann-La Roche Main Business
Table 116. F. Hoffmann-La Roche Latest Developments
Table 117. Sanofi Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. Sanofi Genetically Modified Drug Product Portfolios and Specifications
Table 119. Sanofi Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Sanofi Main Business
Table 121. Sanofi Latest Developments
Table 122. Novartis Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 123. Novartis Genetically Modified Drug Product Portfolios and Specifications
Table 124. Novartis Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Novartis Main Business
Table 126. Novartis Latest Developments
Table 127. Eli Lilly Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 128. Eli Lilly Genetically Modified Drug Product Portfolios and Specifications
Table 129. Eli Lilly Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Eli Lilly Main Business
Table 131. Eli Lilly Latest Developments
Table 132. Takeda Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 133. Takeda Genetically Modified Drug Product Portfolios and Specifications
Table 134. Takeda Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Takeda Main Business
Table 136. Takeda Latest Developments
Table 137. Baxter Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 138. Baxter Genetically Modified Drug Product Portfolios and Specifications
Table 139. Baxter Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Baxter Main Business
Table 141. Baxter Latest Developments
Table 142. GlaxoSmithKline Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 143. GlaxoSmithKline Genetically Modified Drug Product Portfolios and Specifications
Table 144. GlaxoSmithKline Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. GlaxoSmithKline Main Business
Table 146. GlaxoSmithKline Latest Developments
LIST OF FIGURES
Figure 1. Picture of Genetically Modified Drug
Figure 2. Genetically Modified Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Genetically Modified Drug Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Genetically Modified Drug Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Genetically Modified Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Genetically Modified Drug Sales Market Share by Country/Region (2025)
Figure 10. Genetically Modified Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Transgenic Animal
Figure 12. Product Picture of Transgenic Plant
Figure 13. Global Genetically Modified Drug Sales Market Share by Type in 2026
Figure 14. Global Genetically Modified Drug Revenue Market Share by Type (2021-2026)
Figure 15. Genetically Modified Drug Consumed in Hospital
Figure 16. Global Genetically Modified Drug Market: Hospital (2021-2026) & (K Units)
Figure 17. Genetically Modified Drug Consumed in Clinic
Figure 18. Global Genetically Modified Drug Market: Clinic (2021-2026) & (K Units)
Figure 19. Global Genetically Modified Drug Sale Market Share by Application (2025)
Figure 20. Global Genetically Modified Drug Revenue Market Share by Application in 2026
Figure 21. Genetically Modified Drug Sales by Company in 2026 (K Units)
Figure 22. Global Genetically Modified Drug Sales Market Share by Company in 2026
Figure 23. Genetically Modified Drug Revenue by Company in 2026 ($ millions)
Figure 24. Global Genetically Modified Drug Revenue Market Share by Company in 2026
Figure 25. Global Genetically Modified Drug Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Genetically Modified Drug Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Genetically Modified Drug Sales 2021-2026 (K Units)
Figure 28. Americas Genetically Modified Drug Revenue 2021-2026 ($ millions)
Figure 29. APAC Genetically Modified Drug Sales 2021-2026 (K Units)
Figure 30. APAC Genetically Modified Drug Revenue 2021-2026 ($ millions)
Figure 31. Europe Genetically Modified Drug Sales 2021-2026 (K Units)
Figure 32. Europe Genetically Modified Drug Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Genetically Modified Drug Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Genetically Modified Drug Revenue 2021-2026 ($ millions)
Figure 35. Americas Genetically Modified Drug Sales Market Share by Country in 2026
Figure 36. Americas Genetically Modified Drug Revenue Market Share by Country (2021-2026)
Figure 37. Americas Genetically Modified Drug Sales Market Share by Type (2021-2026)
Figure 38. Americas Genetically Modified Drug Sales Market Share by Application (2021-2026)
Figure 39. United States Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Genetically Modified Drug Sales Market Share by Region in 2026
Figure 44. APAC Genetically Modified Drug Revenue Market Share by Region (2021-2026)
Figure 45. APAC Genetically Modified Drug Sales Market Share by Type (2021-2026)
Figure 46. APAC Genetically Modified Drug Sales Market Share by Application (2021-2026)
Figure 47. China Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 51. India Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Genetically Modified Drug Sales Market Share by Country in 2026
Figure 55. Europe Genetically Modified Drug Revenue Market Share by Country (2021-2026)
Figure 56. Europe Genetically Modified Drug Sales Market Share by Type (2021-2026)
Figure 57. Europe Genetically Modified Drug Sales Market Share by Application (2021-2026)
Figure 58. Germany Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 59. France Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Genetically Modified Drug Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Genetically Modified Drug Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Genetically Modified Drug Sales Market Share by Application (2021-2026)
Figure 66. Egypt Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Genetically Modified Drug in 2026
Figure 72. Manufacturing Process Analysis of Genetically Modified Drug
Figure 73. Industry Chain Structure of Genetically Modified Drug
Figure 74. Channels of Distribution
Figure 75. Global Genetically Modified Drug Sales Market Forecast by Region (2027-2032)
Figure 76. Global Genetically Modified Drug Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Genetically Modified Drug Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Genetically Modified Drug Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Genetically Modified Drug Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Genetically Modified Drug Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Genetically Modified Drug
Figure 2. Genetically Modified Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Genetically Modified Drug Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Genetically Modified Drug Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Genetically Modified Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Genetically Modified Drug Sales Market Share by Country/Region (2025)
Figure 10. Genetically Modified Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Transgenic Animal
Figure 12. Product Picture of Transgenic Plant
Figure 13. Global Genetically Modified Drug Sales Market Share by Type in 2026
Figure 14. Global Genetically Modified Drug Revenue Market Share by Type (2021-2026)
Figure 15. Genetically Modified Drug Consumed in Hospital
Figure 16. Global Genetically Modified Drug Market: Hospital (2021-2026) & (K Units)
Figure 17. Genetically Modified Drug Consumed in Clinic
Figure 18. Global Genetically Modified Drug Market: Clinic (2021-2026) & (K Units)
Figure 19. Global Genetically Modified Drug Sale Market Share by Application (2025)
Figure 20. Global Genetically Modified Drug Revenue Market Share by Application in 2026
Figure 21. Genetically Modified Drug Sales by Company in 2026 (K Units)
Figure 22. Global Genetically Modified Drug Sales Market Share by Company in 2026
Figure 23. Genetically Modified Drug Revenue by Company in 2026 ($ millions)
Figure 24. Global Genetically Modified Drug Revenue Market Share by Company in 2026
Figure 25. Global Genetically Modified Drug Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Genetically Modified Drug Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Genetically Modified Drug Sales 2021-2026 (K Units)
Figure 28. Americas Genetically Modified Drug Revenue 2021-2026 ($ millions)
Figure 29. APAC Genetically Modified Drug Sales 2021-2026 (K Units)
Figure 30. APAC Genetically Modified Drug Revenue 2021-2026 ($ millions)
Figure 31. Europe Genetically Modified Drug Sales 2021-2026 (K Units)
Figure 32. Europe Genetically Modified Drug Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Genetically Modified Drug Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Genetically Modified Drug Revenue 2021-2026 ($ millions)
Figure 35. Americas Genetically Modified Drug Sales Market Share by Country in 2026
Figure 36. Americas Genetically Modified Drug Revenue Market Share by Country (2021-2026)
Figure 37. Americas Genetically Modified Drug Sales Market Share by Type (2021-2026)
Figure 38. Americas Genetically Modified Drug Sales Market Share by Application (2021-2026)
Figure 39. United States Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Genetically Modified Drug Sales Market Share by Region in 2026
Figure 44. APAC Genetically Modified Drug Revenue Market Share by Region (2021-2026)
Figure 45. APAC Genetically Modified Drug Sales Market Share by Type (2021-2026)
Figure 46. APAC Genetically Modified Drug Sales Market Share by Application (2021-2026)
Figure 47. China Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 51. India Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Genetically Modified Drug Sales Market Share by Country in 2026
Figure 55. Europe Genetically Modified Drug Revenue Market Share by Country (2021-2026)
Figure 56. Europe Genetically Modified Drug Sales Market Share by Type (2021-2026)
Figure 57. Europe Genetically Modified Drug Sales Market Share by Application (2021-2026)
Figure 58. Germany Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 59. France Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Genetically Modified Drug Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Genetically Modified Drug Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Genetically Modified Drug Sales Market Share by Application (2021-2026)
Figure 66. Egypt Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Genetically Modified Drug Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Genetically Modified Drug in 2026
Figure 72. Manufacturing Process Analysis of Genetically Modified Drug
Figure 73. Industry Chain Structure of Genetically Modified Drug
Figure 74. Channels of Distribution
Figure 75. Global Genetically Modified Drug Sales Market Forecast by Region (2027-2032)
Figure 76. Global Genetically Modified Drug Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Genetically Modified Drug Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Genetically Modified Drug Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Genetically Modified Drug Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Genetically Modified Drug Revenue Market Share Forecast by Application (2027-2032)
